PRINCETON, N.J. Sandoz has launched a generic version of a prostate drug, the generics arm of Novartis said Monday.
The Swiss drug company announced the launch of tamsulosin hydrochloride capsules in the 0.4-mg strength. The capsules are used to treat benign prostatic hyperplasia, a disorder that affects around 8.4 million men in the United States aged 50 and older.
The drug is a generic version of Flomax, made by Boehringer Ingelheim and Astellas. Various versions of the drug had sales of $2.3 billion during the 12-month period ending in February, according to IMS Health.
Sandoz also launched vancomycin hydrochloride, an injectable antibiotic used to treat staphylococcus and streptococcus infections. The drug, which Sandoz will launch in the 1-g and 500-mg strengths, is a generic version of ViroPharma’s Vancocin, though ViroPharma only markets the drug in oral capsules. According to IMS Health, various versions of the drug had sales of $91 million during the same 12-month period.